When prostate cancer treatments are mismatched

Ronald Chen, MD of the MGH Cancer Center, together with co-authors Jack Clark, MD of the Boston University School of Public Health, and Judith Manola, MS of the Dana-Farber Cancer Institute recently conducted a study on prostrate cancer. Based on their data, it seems like the quality of life factors may not receive adequate consideration when it comes to matching treatments with patients. This seems to stem from the fact that unlike other types of cancers, prostrate deals with subjects that many patients might be uncomfortable discussing even with a doctor.

As James Talcott, MD says, “Prostate cancer patients experience the same fears and hard decisions as all cancer patients do, but prostate cancer treatment directly affects very personal things that most people aren’t comfortable talking about – urinary, bowel and sexual function.”

To read the news in full, please click here.

Photo credits: Wikipedia